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Abstract
Context: Paranoia embodies altered representation of the social environment, fuelling altered feelings of social acceptance
leading to further mistrust. Mindfulness-based cognitive therapy (MBCT) may relieve paranoia and reduce its impact on
social acceptance.
Objective: To determine whether MBCT alters momentary feeling of paranoia and social acceptance in daily life.
Design: Randomized controlled trial of daily-life repeated measures (up to 120 per participant) before and after allocation to
MBCT or waiting list control.
Participants: Volunteer sample of 130 eligible men and women with residual affective dysregulation after at least one
episode of major depressive disorder.
Interventions: Eight weeks of MBCT in groups of 10–15 participants in addition to participants’ usual treatment.
Outcome Measures: Daily-life ratings of paranoia and social acceptance. This manuscript concerns additional analyses of
the original trial; hypotheses were developed after data collection (focus initially on depressive symptoms) but before data
analysis.
Results: Sixty-six participants were assigned to the waiting list control group and 64 to the MBCT intervention group, of
whom 66 and 61 respectively were included in the per-protocol analyses. Intention-to-treat analyses revealed a significant
group by time interaction in the model of momentary paranoia (b =2.18, p,0.001, d =20.35) and social acceptance
(b = .26, p,0.001, d = 0.41). Paranoia levels in the intervention group were significantly reduced (b =2.11, p,0.001) and
feelings of social acceptance significantly increased (b = .18, p,0.001), whereas in the Control condition a significant
increase in paranoia (b = .07, p = 0.008) and a decrease in social acceptance was apparent (b =2.09, p = 0.013). The
detrimental effect of paranoia on social acceptance was significantly reduced in the MBCT, but not the control group (group
by time interaction: b = .12, p = 0.022).
Conclusions: MBCT confers a substantial benefit on subclinical paranoia and may interrupt the social processes that
maintain and foster paranoia in individuals with residual affective dysregulation.
Trial Registration: Netherlands Trial Register NTR1084
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Introduction
Humans have always been social animals. The social world is an
important source of satisfaction and support for most of us.
However, social contact can also be a source of suffering and
problems. Individuals with a diagnosis of mental disorder often
have difficulties to adapt to the social world and to trust others [1].
Although representations of social mistrust are common also in the
general population, they generally take on more severe forms in
the context of mental disorders [2]. Two important factors which
fuel paranoia are low self-esteem [3], expectation of mistreatment
and affective dysregulation [4,5], illustrating the transdiagnostic
nature of paranoia. Paranoia consequently is not only commonly
observed in individuals with psychosis but also in individuals with
affective disorders such as depression, [5,6]. The presence of
paranoid symptoms impacts negatively on outcome even when
expressed at subclinical level [7], and increases the risk for
developing a full-blown psychotic disorder [8]. Paranoia affects
representations of the social environment, resulting in unease in
social situations and reduced social approach. The resulting social
avoidance will further fuel mistrust, giving rise to a downward
spiral [9]. Recent research proposes that mindfulness-based
approaches, for instance Mindfulness-Based Cognitive Therapy
(MBCT) and Acceptance and Commitment Therapy (ACT), are
effective in treating different forms of psychopathology. Most
studies were conducted in patients with depression or anxiety
disorder [10,11], but a few small randomized controlled trials have
reported positive effects of ACT and MBCT for patients
recovering from acute psychosis [12,13,14,15,16,17,18]. There is
little work on possible psychological processes that might be
transformed by of mindfulness-based therapies [19,20], particu-
larly in terms of examining alterations in the subtle dynamic
interplay of altered representations and social interaction in real
life, for example when people interact with others, or when they
feel suspicious. Real-time and real-world assessment approaches
such as the Experience Sampling Method (ESM) have been
optimized for the investigation of dynamic patterns of interaction
between experience and behaviour [21].
Mindfulness-based approaches, unlike cognitive therapy, are
not aimed at changing the contents of mental experience, but
rather target the relationship the individual has with thoughts and
feelings [22]. Participants practice to become more aware of
moment-to-moment sensations and to recognize negative feelings/
thoughts, without being wrapped up in them or considering them to
be a reflection of reality. This practice may bring about the ability
to deal with feelings of insecurity and paranoia.
In a sample of participants with affective dysregulation and
increased risk to experience feelings of mistrust, ESM was used to
measure feelings of paranoia and appraisal of social interactions
during six days before and six days after either MBCT or waiting
list control group (hereafter: Control). This study used data
pertaining to a published RCT on the effects of MBCT on
depressive symptoms [23], to test further hypotheses, developed
after completion of the RCT, regarding the effects of MBCT on
paranoia. The primary aim of the study was to examine the effects
of MBCT on feelings of paranoia and on the appraisal of social
situations, measured as they occur in daily life. A secondary aim
was to investigate whether MBCT may interrupt the downward
spiral between feeling paranoid and feeling less accepted in social
situations, using time-lagged analyses.
The hypothesis was that, following MBCT, individuals would
feel (i) less paranoid and (ii) more at ease during social interaction.
Furthermore, following MBCT, we expected (iii) a reduction of the




In the MindMaastricht study (trial number NTR1084, Nether-
lands Trial Register Trial registration: http://www.trialregister.
nl/trialreg/admin/rctview.asp?TC=1084) [23], adults with re-
sidual depressive symptomatology (.=7 on the 17-item Hamilton
Depression Rating Scale; HDRS [24]) after at least one episode of
Major Depressive Disorder (MDD) and thus at risk of also
displaying elevated paranoid ideation [7], were recruited from
outpatient mental health care facilities in Maastricht and through
posters in public spaces. As the focus was on stable residual
symptomatology in the context of a previous affective disorder,
individuals were excluded if they met SCID criteria for a current
depressive episode, schizophrenia, or any psychotic disorder in the
past year, and recent (past four weeks) or upcoming changes in
ongoing psychological or pharmacological treatment. Sample
sociodemographic and clinical characteristics are displayed in
Table 1.
Sampling procedures
All study procedures were approved by the Medical Ethics
Committee of Maastricht University Medical Centre, and all
participants signed an informed consent form. The protocol for
this trial and supporting CONSORT checklist are available as
initial screening was performed by phone to check for availability
during the study period and likelihood of meeting inclusion and
exclusion criteria. A second screening included administration of
the Structured Clinical Interview for DSM IV axis I (SCID-I) [25]
and the 17-item HDRS by trained psychologists. Eligible
participants were invited for a detailed explanation of the
experience sampling procedure, and then took part in the baseline
assessment. The baseline assessment consisted of six days of
experience sampling in the participant’s natural environment (see
below). After the baseline assessment, participants were random-
ized to either MBCT or waiting list (allocation ratio 1:1). After
either eight weeks of MBCT (see below) or equivalent waiting time
(Control condition), participants again took part in six days of
experience sampling. All participants were compensated with gift
vouchers worth 50 Euros. Participants in the Control condition
had the opportunity to take part in MBCT after the post-
intervention assessment.
Randomization
Randomization to treatment condition was stratified according
to number of depressive episodes (two or less versus three or more),
as at the time of randomization studies suggested a greater benefit
for those with three or more previous episodes [26]. An
independent researcher not involved in the project generated the
randomization sequence in blocks of five (using the sequence
generator on www.random.org), and wrote the randomization
code into sealed numbered envelopes. After completion of all
baseline assessments, the researcher allocated participants to their
treatment condition based on the randomization code in the sealed
envelope (opened in order of sequence). No masking of treatment
condition took place.
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supporting information; see Checklist S`1 and Protocol S1. An
Intervention (MBCT)
Content of MBCT training sessions followed the protocol of
Segal, Williams, and Teasdale [27]. Training consisted of eight
weekly meetings lasting 2.5 hours and were run in groups of 10–15
participants. Assessment periods for control participants were
matched to those of MBCT participants. Sessions included guided
meditation, experiential exercises, and discussions. In addition to
the weekly group sessions, participants received CDs with guided
exercises and were assigned daily homework exercises (30 to
60 minutes daily). Training sessions were given by experienced
trainers in a centre specialized in mindfulness trainings. All
trainers were supervised by an experienced health care profes-
sional who had trained with Teasdale and Williams, the co-
developers of MBCT [28].
Experience Sampling Method and Measures
ESM is a momentary assessment method to repeatedly assess
participants in their daily living environment. Compared to
retrospective questionnaires and interviews, ESM offers several
advantages: (a) enhanced ecological validity, (b) minimized
retrospective bias, because participants’ experiences are assessed
as they occur, and (c) enhanced reliability, because participants’
experiences are assessed repeatedly [29]. In the current study,
participants received a digital wristwatch and a set of ESM self-
assessment forms collated in a booklet for each day. The
wristwatch was programmed to emit a signal (‘‘beep’’) at an
unpredictable moment in each of ten 90-minute time blocks
between 7:30 am and 10:30 pm, on six consecutive days, resulting
in a maximum of 60 beeps per study period. After each beep,
participants were asked to fill out ESM self-assessment forms,
collecting reports of current emotions, cognition and context. All
self-assessments were rated on 7-point Likert scales (ranging from
not at all to very). Trained research assistants explained the ESM
procedure to the participants during an initial briefing session, and
a practice form was completed to confirm that participants
understood the 7-point Likert scale. Participants were instructed to
complete their reports immediately after the beep, thus minimizing
memory distortion, and to record the time at which they
completed the form. All reports not filled in within 15 min after
the actual beep were excluded from the analysis, since previous
work has shown that reports completed after this interval are less
reliable and consequently less valid. For the same reason,
participants with less than 20 valid reports at baseline were
excluded from the analysis [30]. Previous studies have demon-
strated the feasibility, validity, and reliability of ESM in general
and patient populations [21].
Momentary paranoid feelings. In accordance with previ-
ous work [31], momentary paranoia was measured with the ESM
item I feel suspicious.
Momentary social acceptance. In case participants were
not alone at the time of the beep, they evaluated their social
company in terms of social acceptance (In this company, I feel accepted)
[32].
Statistical Methods
ESM data have a hierarchical structure. Thus, multiple
observations (level 1) are clustered within participants (level 2).
Note that assessment period (pre/post) is not a separate level but
an independent factor, just as in regular regression analyses.
Multilevel analyses take the variability associated with each level of
nesting into account [33]. Multilevel linear regression analyses,
using the XTREG command on a Windows platform in Stata 11.1
were applied to the ESM data.
First, we examined the effects of MBCT on change in paranoia
and feelings of social acceptance relative to the Control condition.
Thus, in the models of paranoia and feelings of social acceptance,
the two-way interaction between study period (baseline vs. post
assessment) and treatment group (Control vs. MBCT) was the
parameter of interest.
Second, we examined whether MBCT changed the time-lagged
association between paranoia and feelings of social acceptance in
the flow of daily life compared to the Control condition. To this
end, we analysed the three-way interaction between study period
(baseline vs. post assessment), treatment group (Control vs.
MBCT), and paranoia at time point t-1 on feeling accepted at
time point t and respectively with feeling accepted at time point t-1
on paranoia at time point t. In case of significant interactions,
stratified effects were calculated for the four different conditions
(MBCT and Control, at baseline and post-intervention). Within
each treatment group, statistical significance of differences
between baseline and post-assessment was assessed by Wald test
[34].
The reported analyses are based on the whole sample (intention
to treat). Participants who attended less than four MBCT sessions
(n=3) were excluded for the per-protocol analysis (outcomes were
similar and are not reported).
Results
Participants
Recruitment of participants started in January 2008 and ended
in February 2009, and all post-intervention assessments were
completed by August 2009, when the pre-determined number of
participants was reached. Sociodemographic and clinical charac-
teristics of MBCT and Control participants are displayed in
Table 1. At baseline, there were no large or significant differences
between treatment groups with respect to sociodemographic and
clinical characteristics. Table 2 shows baseline and post assessment
scores of variables used in the analyses, stratified by treatment
group. Again, there were no large or significant differences
between groups at baseline. The baseline overall mean of
momentary paranoia was 1.65 (SD=1.27, range= 1–7). Partici-
pant flow through the study can be found in an earlier publication
[35]. No known harms or unintended treatment effects were
reported in either group.
Table 1. Baseline demographic and clinical characteristics in
each group.
MBCT (n=63) Control (n =66)
Age (mean, SD) 44.6 (9.7) 43.2 (9.5)
Female gender 79% 73%
Full-/part-time work 62% 68%
Illness/unemployment benefits 19% 23%
Living with partner/own family 64% 64%
Comorbid anxiety disorder (present) 35% 49%
Comorbid anxiety disorder (past) 51% 64%
Current psycho-counseling/-therapy 13% 12%
Current use of antidepressants 32% 38%
(Occasional) use of benzodiazepines 8% 8%
Note. There were no significant differences between groups (at p,0.05).
MBCT=Mindfulness-based cognitive therapy; Control =waiting list control
condition.
doi:10.1371/journal.pone.0066747.t001
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Participants completed 12,453 ESM entries. Of these, 559 (4%)
were excluded as invalid entries, because completion times fell
outside the pre-determined window of 15 minutes after the beep.
On average, participants completed 49 (of 60; SD=7.6) valid
entries per ESM assessment period. One participant had
completed fewer than 20 valid entries at baseline and was
therefore excluded from the analyses.
Effects of MBCT on paranoia and social acceptance
Multilevel analysis revealed a significant interaction between
treatment group and study period in the model of momentary
paranoia (b =2.18; 95%CI2.25,2.10, p,0.001; d =20.35); the
MBCT group reported significantly reduced feelings of paranoia
from pre- to post-assessment (b =2.11; 95%CI 2.16, 2.05,
p,0.001), whereas in the Control condition a significant increase
was apparent (b = .07; 95%CI .02, .12, p = 0.008).
Similarly, significant interactions between treatment group and
study period were apparent for the variable I feel accepted (b = .26;
95%CI .16, .36, p,0.001; d = 0.41). Thus, MBCT participants
felt more accepted after the MBCT training (b= .18; 95%CI .13,
.25, p,0.001), compared to before, whereas Control participants
felt less accepted after the waiting period (b=2.09; 95%CI 2.16,
.02, p = 0.013). For baseline and post-assessment means and effect
sizes, see Table 2.
MBCT and time-lagged associations between paranoia
and feeling accepted
MBCT compared to Control was associated with a significant
change in the effect of paranoia on prospective feelings of social
acceptance between pre- and post-treatment (b = .12; 95%CI .02,
.21, p = 0.022). Before MBCT, feeling more suspicious was
associated with feeling less accepted the next moment (b =2.06;
95%CI 2.11, 2.02, p= 0.002). After MBCT, the association
between feeling suspicious at t-1 and feeling less accepted at t
disappeared (b = .03; 95%CI 2.03, .10, p = 0.30)(Figure 1 and
Figure 2), while in the Control condition, the association remained
and feeling more suspicious was associated with feeling less
accepted the next moment both pre- (b =2.07; 95%CI 2.12,
2.02, p = 0.004) and post-measurement (b =2.08; 95%CI 2.14,
2.03, p = 0.003).
No difference was found between MBCT compared to Control
with respect to the effect of social acceptance on prospective
feelings of paranoia between pre- and post-treatment (b = .04;
95%CI 2.06, .14, p = 0.43). Overall, feeling less accepted resulted
in feeling more suspicious the next moment (b =2.06; 95%CI
2.08, 2.03, p,0.001), illustrating the vicious circle between these
two variables (see Figure 1 and Figure 2). All results remained
significant and similar when controlling for momentary paranoia
at t.
Discussion
This is the first daily life study to show that MBCT changes the
way in which individuals with affective dysregulation deal with
feelings of insecurity and paranoia in the social world. Our results
indicate that MBCT decreases feelings of paranoia in the flow of
daily life, while paranoia grew worse in the control group.
Moreover, MBCT significantly increased feeling accepted in social
situations while controls reported reduced social acceptance from
baseline to follow-up. A bi-directional link between feeling
paranoid and feeling accepted was apparent, which was attenuated
as a result of MBCT, suggesting that MBCT interrupts the vicious
circle of feeling paranoid and not feeling accepted (see Figure 1
and Figure 2). This interruption seems to particularly take place
between paranoia and social acceptance the next moment, but not
between feeling accepted on paranoid feeling the next moment.
Improvements in social interaction (because of their central
importance for human beings) may be one of the indirect
Table 2. Baseline and post-assessment means and standard deviations of experience sampling variables used in the analyses,
stratified by group.










M SD M SD M SD M SD
I feel suspicious 1.63 1.27 1.48 1.04 ,0.001 2.13 1.67 1.28 1.72 1.25 0.008 .04
I feel accepted 5.91 1.19 6.09 1.06 ,0.001 .16 5.98 1.28 5.88 1.2 0.013 2.08
MBCT sessions attended 7.2 1.5
Minutes practiced per day 29.7 13.2
Note. MBCT =Mindfulness-based cognitive therapy plus treatment as usual; Control =waiting list control condition (treatment as usual); M =mean; SD= Standard
deviation.
doi:10.1371/journal.pone.0066747.t002
Figure 1. Time-lagged associations between feeling paranoid
and feeling accepted in the flow of daily life: baseline and post-
Mindfulness-based cognitive therapy (MBCT).
doi:10.1371/journal.pone.0066747.g001
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mechanisms underlying the beneficial effects of mindfulness-based
interventions in depression. Feeling paranoid and not accepted
during social interaction may become detrimental for wellbeing,
leading to increased isolation [9]. Earlier work shows that
dispositional and state mindfulness predict self-regulatory behav-
iour and positive emotional states [36]. Thereby, MBCT may
prevent individuals from becoming socially isolated and develop-
ing additional symptoms, for example social anhedonia. More-
over, the interpretation of events is at the heart of affective
dysregulation, according to influential cognitive theories [37].
MBCT may weaken the impact of paranoia on affective
dysregulation by promoting a different relationship to intrusive
thoughts (aware yet detached; [38]) as well as self-compassion [39].
By affecting paranoia and its impact on a network of are causally
linked symptoms [40], MBCT may be able to prevent a cascade of
symptoms that would normally result in a worse prognosis and
increased risk for need for care in individuals with affective
dysregulation. Therefore, MBCT may be particularly suited for
individuals suffering from (sub-clinical) paranoia. In early inter-
vention, circular processes that otherwise would take place and
induce shifts upward the psychosis continuum may be prevented.
ESM is ideally suited to examine these interactions at the most
fundamental ‘‘micro-level’’ expression of psychopathology [41]
and to examine directionality of momentary processes and the
smallest building blocks that may eventually form part of a mental
illness. More research is necessary to investigate whether MBCT
also improves feeling accepted during social interaction when
feelings of paranoia are more pronounced (e.g., as in individuals in
an acute psychotic episode or at ultra-high risk to develop a
psychotic disorder).
Only a handful of small RCTs using mindfulness-based
therapies in participants with psychotic symptoms exist and it is
difficult to compare the current study with earlier work because of
differences in sample characteristics (sub-clinical feelings of
suspiciousness vs. psychotic patients) and employed methodology
(experience sampling vs. retrospective questionnaires). Two small
randomized trials showed that ACT significantly reduces distress
related to hallucinations [42,43] as well as re-hospitalization for in-
patients with psychosis [18], with effects extending to up to 1 year
post-discharge [44]. Three other studies in individuals with a
psychotic disorder examined the effect of MBCT [14,15,16]
compared to waiting list control conditions and found improve-
ments in clinical functioning and mindfulness. Recently, improve-
ments in psychological symptoms, command hallucinations,
negative symptoms, depression and crisis contacts were reported
after mindfulness-based therapies in psychosis [6,45,46]. Our
findings extend these findings to real-life paranoia in the context of
major mood disorder, and provide a framework for an
understanding of the (psychological) mechanisms underlying these
positive clinical changes.
Some strengths and limitations of the current RCT should be
mentioned. An important observation is that conclusions are
limited to subclinical paranoia. One limitation concerns the
absence of an active control group. Moreover, we had no measure
of MBCT fidelity with respect to both adherence and competence.
For some of the ESM variables used in the current study, single
Figure 2. The effect of Mindfulness-based cognitive therapy (MBCT) on feeling accepted, feeling paranoid and their association
compared to the control condition: Overview of the main results.
doi:10.1371/journal.pone.0066747.g002
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item measures were used. ESM requires selectivity in choosing
one’s items, because participants have to answer them so
frequently (in this study, up to 120 times). While construct validity
may suffer due to these restrictions, ecological validity and
reliability of the estimation are strongly boosted [47]. These
particular single-item measures items have been used in several
ESM studies in our research group (e.g. [31]) and have
demonstrated predictive and ecological validity. The momentary
paranoia scores of the current sample with residual mood
complaints were elevated compared to the general population,
but were below the momentary paranoia scores of (paranoid)
psychotic patients.Strengths include the large sample size and
sufficient power for the analysis of group by time interaction
effects. Examining (subclinical) paranoid ideas in a sample with
affective dysregulation has the advantage that patterns underlying
psychosis remain relative plastic, so that changes in psychological
processes related to paranoia may be investigated more easily. The
most important asset of the current study is the use of repeated
assessment of paranoia and social acceptance in daily life, enabling
fine-grained examination of changes in psychological processes.
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